Strata Skin Sciences, Inc.
SSKN
$2.21
$0.010.46%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 19.48% | 6.87% | -30.39% | -16.48% | -93.18% |
| Total Depreciation and Amortization | -8.29% | -10.08% | -10.60% | -4.42% | -0.62% |
| Total Amortization of Deferred Charges | 20.00% | 5.71% | -10.46% | -22.56% | -19.25% |
| Total Other Non-Cash Items | -9.06% | -4.77% | 43.99% | 43.02% | 197.80% |
| Change in Net Operating Assets | -78.29% | 1,097.10% | 162.90% | -0.51% | 117.83% |
| Cash from Operations | 187.35% | 136.22% | 150.03% | -123.90% | 63.54% |
| Capital Expenditure | 71.91% | 67.40% | 43.00% | 54.66% | 18.50% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 71.91% | 67.40% | 43.00% | 54.66% | 18.50% |
| Total Debt Issued | -- | -- | -100.00% | -100.00% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 87.05% | 97.18% | 77.20% | 68.60% |
| Cash from Financing | -71.61% | -71.94% | -69.74% | -101.89% | 1,468.60% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -46.54% | -63.95% | 80.29% | -1,096.66% | 135.40% |